Sanofi acquires Dynavax for $2.2B, $15.50 per share, boosting adult immunizations. Dynavax stock surges.
A significant acquisition was announced as Sanofi revealed its plan to purchase vaccine manufacturer Dynavax Technologies for $2.2 billion, which amounts to $15.50 per share. This acquisition is intended to bolster Sanofi's portfolio in the field of adult immunizations. Following this news, Dynavax Technologies' stock surged.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments